Torrent Pharmaceuticals Limited has informed the Exchange about Investor Presentation

23rd October, 2023

The Dy. General Manager (Listing Dept.) BSE Limited, Corporate Relationship Dept., 1st Floor, New Trading Ring, P. J. Towers, Dalal Street, Fort, Mumbai - 400 001 (BSE Scrip Code: 500420)

The Manager – Listing Dept., National Stock Exchange of India Ltd., Exchange Plaza, 5th Floor, Plot No. C/1, G. Block, Bandra - Kurla Complex, Bandra (E), Mumbai – 400 051 (NSE Scrip Code: TORNTPHARM)

Dear Sir,

Sub.: Presentation to analysts on unaudited Consolidated Financial Results for the quarter

and half year ended 30th September, 2023

The Presentation on unaudited Consolidated Financial Results for the quarter and half year ended 30th September, 2023 to be made to analysts is enclosed for your records.

Thanking you,

Yours sincerely,

For TORRENT PHARMACEUTICALS LIMITED

CHINTAN M. TRIVEDI COMPANY SECRETARY

Encl : A/a

___________________________________________________________________________________ TORRENT PHARMACEUTICALS LIMITED CIN: L24230GJ1972PLC002126 Reg.Office : Torrent House, Off Ashram Road, Ahmedabad- 380 009, India. Phone: +91 79 26599000, Fax: +91 79 26582100, www.torrentpharma.com, Email : InvestorServices@TorrentPharma.com

Q2 FY 2023-24

Revenues: Summary

1

Revenue: Summary

Revenues (Rs cr)

Q2 FY24

Q2 FY23

India

United States

Germany

Brazil

Other countries

Others

Total

1,444

1224

248

266

252

280

170

292

220

185

239

131

2,660

2,291

Gr%

18%

-15%

21%

36%

17%

30%

16%

2